Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

Wuxi's Biologics Facility Receives Honorable Mention at ISPE Facility of the Year Awards 2014

October 20, 2014

The WuXi AppTec bulk cell culture production facility, designed by Sartorius Stedim Biotech (SSB), received an honorable mention in the 2014 Facility of the Year Awards at the annual meeting of International Society for Pharmaceutical Engineering (ISPE) in Las Vegas last week.

Nuvilex Applies for Orphan Drug Designation for Pancreatic Cancer Treatment

October 16, 2014

The company submits an orphan drug application to FDA for its Cell-in-a-Box treatment for pancreatic cancer.

BioReliance Adds Advanced In-Vitro ADME and Toxicology Services

October 16, 2014

BioReliance has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services its service offering. The company?s range of predictive assays use a novel suite of genetically modified cell lines created with CompoZr zinc finger nuclease (ZFN), a Sigma-Aldrich proprietary technology.

CSL Behring Announces Global Facility Expansions

October 9, 2014

CSL Behring announced that it plans to invest $450 million to expand its Melbourne, Australia and Kankakee, Illinois facilities, which will increase production of albumin and plasma intermediates.

CPhI Releases Part 3 of its Annual Industry Report

October 9, 2014

CPhI released Part 3 of its annual industry report featuring three experts in the pharmaceutical industry.

Genentech Receives FDA Priority Review for Diabetic Retinopathy Treatment

October 9, 2014

FDA granted Genentech priority review for its diabetic retinopathy treatment, Lucentis.

Change is Afoot at CPhI

October 8, 2014

New investments, expansions, and company rebranding are discussed at CPhI.

FDA Releases Guidance on OTC Pediatric Drug Products

October 7, 2014

FDA draft guidance outlines ways to minimize risk from acetaminophen-containing over-the-counter pediatric liquid drug products.

FDA Releases Q&A on DQSA

October 7, 2014

FDA releases question and answer draft guidance on drug product tracing and licensing requirements.

ADVERTISEMENT

ADVERTISEMENT

Click here